Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate in Treatment-Naïve Patients With Primary Biliary Cholangitis
NCT07296458Phase 3Recruiting
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Dec 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenofibrate in primary biliary cholangitis (PBC), sponsored by Xijing Hospital of Digestive Diseases. Started Dec 2025; status: recruiting.
02
Drugs
fenofibrate
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT07296458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07296458.